Format

Send to

Choose Destination
Expert Opin Biol Ther. 2008 Nov;8(11):1659-67. doi: 10.1517/14712598.8.11.1659 .

Personalized vaccines: the emerging field of vaccinomics.

Author information

1
Mayo Clinic College of Medicine, Mayo Vaccine Research Group, Program in TranslationalImmunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota 55905, USA. poland.gregory@mayo.edu

Abstract

The next 'golden age' in vaccinology will be ushered in by the new science of vaccinomics. In turn, this will inform and allow the development of personalized vaccines, based on our increasing understanding of immune response phenotype: genotype information. Rapid advances in developing such data are already occurring for hepatitis B, influenza, measles, mumps, rubella, anthrax and smallpox vaccines. In addition, newly available data suggest that some vaccine-related adverse events may also be genetically determined and, therefore, predictable. This paper reviews the basis and logic of personalized vaccines, and describes recent advances in the field.

PMID:
18847302
PMCID:
PMC2831634
DOI:
10.1517/14712598.8.11.1659
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center